Balyasny Asset Management LLC Eli Lilly & CO Call Options Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $4.86 Million - $6.05 Million	6,300 Added 262.5%	8,700 $7.71 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $144,974 - $181,808	200 Added 9.09%	2,400 $2.17 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $4.68 Million - $6.26 Million	-7,900 Reduced 78.22%	2,200 $1.71 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $3.73 Million - $4.4 Million	7,100 Added 236.67%	10,100 $5.89 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $1.3 Million - $1.8 Million	3,000 New	3,000 $1.61 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $151 Million - $177 Million	541,500 Added 5415.0%	551,500 $179 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $1.44 Million - $1.77 Million	6,500 Added 185.71%	10,000 $2.31 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $631,925 - $817,390	3,500 New	3,500 $803,000
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $91.6 Million - $119 Million	-557,500 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $68.8 Million - $91.1 Million	527,500 Added 1758.33%	557,500 $94.1 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $10.2 Million - $11.8 Million	-70,000 Reduced 70.0%	30,000 $4.44 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $13.6 Million - $16.4 Million	100,000 New	100,000 $16.4 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $5.95 Million - $7.37 Million	-50,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $17.6 Million - $21.9 Million	-165,000 Reduced 76.74%	50,000 $6.57 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $9.27 Million - $10.6 Million	-122,500 Reduced 36.3%	215,000 $18.3 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $25 Million - $29.6 Million	337,500 New	337,500 $26.1 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$73 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$55.6 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$49.6 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$38.7 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$25.5 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account